Author: Iba, Toshiaki; Levy, Jerrold H.; Connors, Jean Marie; Warkentin, Theodore E.; Thachil, Jecko; Levi, Marcel
Title: The unique characteristics of COVID-19 coagulopathy Cord-id: t319flz3 Document date: 2020_6_18
ID: t319flz3
Snippet: Thrombotic complications and coagulopathy frequently occur in COVID-19. However, the characteristics of COVID-19-associated coagulopathy (CAC) are distinct from those seen with bacterial sepsis-induced coagulopathy (SIC) and disseminated intravascular coagulation (DIC), with CAC usually showing increased D-dimer and fibrinogen levels but initially minimal abnormalities in prothrombin time and platelet count. Venous thromboembolism and arterial thrombosis are more frequent in CAC compared to SIC/
Document: Thrombotic complications and coagulopathy frequently occur in COVID-19. However, the characteristics of COVID-19-associated coagulopathy (CAC) are distinct from those seen with bacterial sepsis-induced coagulopathy (SIC) and disseminated intravascular coagulation (DIC), with CAC usually showing increased D-dimer and fibrinogen levels but initially minimal abnormalities in prothrombin time and platelet count. Venous thromboembolism and arterial thrombosis are more frequent in CAC compared to SIC/DIC. Clinical and laboratory features of CAC overlap somewhat with a hemophagocytic syndrome, antiphospholipid syndrome, and thrombotic microangiopathy. We summarize the key characteristics of representative coagulopathies, discussing similarities and differences so as to define the unique character of CAC.
Search related documents:
Co phrase search for related documents- activate neutrophil and acute lung injury: 1
- activate neutrophil and acute respiratory syndrome: 1, 2
- acute kidney injury and admission platelet: 1, 2, 3
- acute respiratory syndrome and additional criterion: 1, 2, 3, 4
- acute respiratory syndrome and admission platelet: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
Co phrase search for related documents, hyperlinks ordered by date